State Street’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Sell |
253,834
-1,025,860
| -80% | -$1.19M | ﹤0.01% | 3732 |
|
|
2025
Q1 | $1.73M | Sell |
1,279,694
-105,542
| -8% | -$142K | ﹤0.01% | 3296 |
|
|
2024
Q4 | $18.2M | Sell |
1,385,236
-17,494
| -1% | -$230K | ﹤0.01% | 2277 |
|
|
2024
Q3 | $15.7M | Buy |
1,402,730
+26,610
| +2% | +$298K | ﹤0.01% | 2352 |
|
|
2024
Q2 | $14.8M | Buy |
1,376,120
+57,353
| +4% | +$617K | ﹤0.01% | 2323 |
|
|
2024
Q1 | $19.6M | Sell |
1,318,767
-16,511
| -1% | -$246K | ﹤0.01% | 2205 |
|
|
2023
Q4 | $24.2M | Buy |
1,335,278
+17,477
| +1% | +$317K | ﹤0.01% | 2108 |
|
|
2023
Q3 | $22.9M | Buy |
1,317,801
+112,861
| +9% | +$1.96M | ﹤0.01% | 2091 |
|
|
2023
Q2 | $21.8M | Buy |
1,204,940
+914,839
| +315% | +$16.6M | ﹤0.01% | 2199 |
|
|
2023
Q1 | $7.72M | Buy |
290,101
+29,276
| +11% | +$779K | ﹤0.01% | 2801 |
|
|
2022
Q4 | $5.04M | Buy |
260,825
+47,244
| +22% | +$913K | ﹤0.01% | 3042 |
|
|
2022
Q3 | $4.46M | Buy |
213,581
+128,113
| +150% | +$2.68M | ﹤0.01% | 3116 |
|
|
2022
Q2 | $685K | Sell |
85,468
-361,528
| -81% | -$2.9M | ﹤0.01% | 3722 |
|
|
2022
Q1 | $3.13M | Buy |
446,996
+2,367
| +0.5% | +$16.6K | ﹤0.01% | 3397 |
|
|
2021
Q4 | $6M | Buy |
444,629
+26,626
| +6% | +$359K | ﹤0.01% | 3150 |
|
|
2021
Q3 | $7.06M | Buy |
418,003
+32,995
| +9% | +$557K | ﹤0.01% | 3060 |
|
|
2021
Q2 | $11.2M | Buy |
385,008
+4,759
| +1% | +$139K | ﹤0.01% | 2855 |
|
|
2021
Q1 | $15M | Buy |
380,249
+199,258
| +110% | +$7.84M | ﹤0.01% | 2535 |
|
|
2020
Q4 | $4.11M | Buy |
180,991
+60,784
| +51% | +$1.38M | ﹤0.01% | 3056 |
|
|
2020
Q3 | $2.72M | Buy |
+120,207
| New | +$2.72M | ﹤0.01% | 3073 |
|